SHL Telemedicine Ltd. (SWX:SHLTN)
1.960
-0.040 (-2.00%)
Apr 25, 2025, 5:31 PM CET
SHL Telemedicine Revenue
In the year 2024, SHL Telemedicine had annual revenue of $56.78M USD, down -0.52%. SHL Telemedicine had revenue of $27.87M in the half year ending June 30, 2024, a decrease of -9.81%.
Revenue
$56.78M
Revenue Growth
-0.52%
P/S Ratio
0.62
Revenue / Employee
$97.39K
Employees
583
Market Cap
32.13M CHF
Revenue Chart
* This company reports financials in USD.
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 56.78M | -296.00K | -0.52% |
Dec 31, 2023 | 57.08M | -1.92M | -3.26% |
Dec 31, 2022 | 59.00M | 9.42M | 18.99% |
Dec 31, 2021 | 49.58M | 9.42M | 23.45% |
Dec 31, 2020 | 40.16M | -1.72M | -4.11% |
Dec 31, 2019 | Pro | Pro | Pro |
Dec 31, 2018 | Pro | Pro | Pro |
Dec 31, 2017 | Pro | Pro | Pro |
Dec 31, 2016 | Pro | Pro | Pro |
Dec 31, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Roche Holding AG | 62.40B |
Novartis AG | 46.87B |
Lonza Group AG | 6.57B |
Alcon | 8.98B |
Galderma Group AG | 4.02B |
Straumann Holding AG | 2.50B |
Sonova Holding AG | 3.71B |
Sandoz Group AG | 9.41B |
SHL Telemedicine News
- 4 months ago - DocGo and SHL Telemedicine Partner to Revolutionize Patient Access to Cardiovascular Care - Business Wire
- 7 months ago - SHL Telemedicine GAAP EPS of -$0.24 misses by $0.07, revenue of $27.9M misses by $1.1M - Seeking Alpha
- 9 months ago - SHL Telemedicine to Appoint David Arnon as CEO of SHL Telemedicine - Business Wire
- 11 months ago - SHL Telemedicine Confirms Discussions Regarding a Possible Investment in its Israeli Activity - Business Wire
- 1 year ago - SHL Telemedicine Expands Offering in Israel With Groundbreaking At-home Biomarker Blood Test - Business Wire
- 1 year ago - SHL Telemedicine Announces Official Launch of SmartHeart® D2C Membership in the US Following Successful Soft Launch - Business Wire
- 1 year ago - SHL Announces Full-Year 2023 Results - Stable Revenue Growth Alongside Groundbreaking Clinical Milestones - Business Wire
- 1 year ago - Imperial College London Study Shows Groundbreaking Final Results for SHL Telemedicine's SmartHeart® in Post-ACS Patient Care - Business Wire